Earnings Labs
4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ·Healthcare·Biotechnology

$8.93

-5.23%

Mkt Cap $479.88M

Analyst Ratings

Buy

7

Hold

0

Sell

0

Price Target (15 analysts)

$25.33

Range $17.00$33.00

Implied Upside

+183.7%

Consensus $25.33 vs current $8.93